JBIO
Jade Biosciences, Inc.
NASDAQ: JBIO · HEALTHCARE · BIOTECHNOLOGY
$24.40
+9.32% today
Updated 2026-04-30
Market cap
$1.32B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.19
Dividend yield
—
52W range
$7 – $28
Volume
0.6M
Jade Biosciences, Inc. (JBIO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | $4.71M | $175.36M | $135.30M | $127.42M | $80.33M |
| Cash & equivalents | $4.57M | $54.20M | $22.40M | $23.49M | $33.75M |
| Current assets | $4.68M | $174.33M | $131.50M | $124.23M | $80.12M |
| Total liabilities | $1.77M | $2.94M | $8.56M | $17.96M | $3.90M |
| Current liabilities | $1.77M | $2.55M | $7.78M | $17.64M | $3.83M |
| Long-term debt | — | — | — | — | — |
| Shareholder equity | $2.94M | $172.42M | $126.74M | $109.46M | $76.43M |
| Retained earnings | $-13.41M | $-36.39M | $-87.90M | $-163.42M | $-233.05M |
| Accounts receivable | — | — | — | — | — |
| Inventory | — | — | — | — | — |
| Goodwill | — | — | — | — | — |